Nalaganje...
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Sclerostin has been proposed as a potent inhibitor of bone formation. Sclerostin antibodies are under clinical development to treat osteoporosis and metastatic bone disease. Serum sclerostin level is elevated in multiple myeloma, an osteolytic malignancy, where it might serve as predictive marker fo...
Shranjeno v:
| izdano v: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5036091/ https://ncbi.nlm.nih.gov/pubmed/27666393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep33551 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|